Mj. Reinhardt et E. Moser, AN UPDATE ON DIAGNOSTIC METHODS IN THE INVESTIGATION OF DISEASES OF THE THYROID, European journal of nuclear medicine, 23(5), 1996, pp. 587-594
Iodine deficiency and iodine-deficiency disorders continue to be probl
ems in several parts of Europe, requiring further improvements in the
techniques employed in thyroid diagnosis, and particularly in the earl
y diagnosis and risk assessment of autonomously functioning thyroid ti
ssue. For the latter purpose, scintigraphy with technetium-99m pertech
netate under exogenous or endogenous thyroid-stimulating hormone (TSH)
suppression provides the best results. Significant methodological imp
rovements in laboratory tests have resulted from the application of ne
w luminescent techniques and gene technology to thyroid function tests
. Especially TSH measurement using second- or third-generation assays
ensures diagnostic accuracy, so that the thyrotropin-releasing hormone
(TRH) test is now almost always unnecessary. The differentiation of b
locking and stimulating TSH receptor antibodies is relevant when discr
epant results are obtained with respect to thyroid function. Determina
tion of glycosaminoglycans in urine may become a helpful tool in the f
ollow-up of endocrine ophthalmopathy. Some new imaging agents have rec
ently been applied in the scintigraphy of thyroid diseases, such as oc
treotide, or in thyroid diagnosis, such as fluorodeoxyglucose. Both im
prove the detectability of metastases of thyroid cancer, especially if
the radioiodine scan is negative.